Genmab A/S (GMAB) News Today $24.87 -0.24 (-0.96%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$24.88 +0.00 (+0.02%) As of 08/29/2025 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GMAB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period 32,341 Shares in Genmab A/S Sponsored ADR $GMAB Purchased by Synovus Financial Corp2 hours ago | marketbeat.comTema Etfs LLC Acquires 43,814 Shares of Genmab A/S Sponsored ADR $GMABAugust 30 at 8:19 AM | marketbeat.comAnalysts Set Genmab A/S Sponsored ADR (NASDAQ:GMAB) Price Target at $37.60August 30 at 3:49 AM | americanbankingnews.comGenmab A/S Sponsored ADR $GMAB Stock Position Raised by American Century Companies Inc.August 30 at 3:42 AM | marketbeat.comCresset Asset Management LLC Has $244,000 Stock Position in Genmab A/S Sponsored ADR $GMABAugust 29 at 3:46 AM | marketbeat.comGenmab A/S Sponsored ADR (NASDAQ:GMAB) Given Average Rating of "Moderate Buy" by BrokeragesAugust 29 at 2:38 AM | marketbeat.comCapital Fund Management S.A. Purchases Shares of 107,523 Genmab A/S Sponsored ADR $GMABAugust 27, 2025 | marketbeat.comGenmab to Participate in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare ConferenceAugust 26, 2025 | globenewswire.comGenmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC)August 26, 2025 | globenewswire.comGenmab A/S (NASDAQ:GMAB) Downgraded to "Hold" Rating by Zacks ResearchAugust 23, 2025 | marketbeat.comRussell Investments Group Ltd. Increases Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)August 19, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for Genmab A/S Q1 Earnings?August 19, 2025 | marketbeat.comBrandywine Global Investment Management LLC Has $33.63 Million Stock Position in Genmab A/S Sponsored ADR (NASDAQ:GMAB)August 18, 2025 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for Genmab A/S (NASDAQ:GMAB) StockAugust 17, 2025 | marketbeat.comWilliam Blair Remains Bullish on Genmab A/S (GMAB)August 12, 2025 | finance.yahoo.comCapital Increase in Genmab as a Result of Employee Warrant ExerciseAugust 12, 2025 | globenewswire.com209,295 Shares in Genmab A/S Sponsored ADR (NASDAQ:GMAB) Acquired by Eagle Global Advisors LLCAugust 12, 2025 | marketbeat.comWhat is William Blair's Forecast for Genmab A/S Q3 Earnings?August 11, 2025 | marketbeat.comPNC Financial Services Group Inc. Has $1.97 Million Stock Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)August 10, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Shares Gap Down - Time to Sell?August 9, 2025 | marketbeat.comGenmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Sold by US Bancorp DEAugust 9, 2025 | marketbeat.comNatixis Advisors LLC Decreases Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)August 9, 2025 | marketbeat.comGenmab’s GEN1286 Study: A New Hope for Advanced Solid TumorsAugust 8, 2025 | msn.comGenmab shares rise on Q2 beat, raised outlook and Epkinly trial successAugust 8, 2025 | ca.investing.comGenmab rises on late-stage trial win for AbbVie-partnered lymphoma therapyAugust 8, 2025 | msn.comGenmab AS (GMAB) Q2 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic AdvancementsAugust 8, 2025 | finance.yahoo.comGenmab A/S (GMAB) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comGenmab A/S 2025 Q2 - Results - Earnings Call PresentationAugust 7, 2025 | seekingalpha.comGenmab Announces Financial Results for the First Half of 2025August 7, 2025 | globenewswire.comGenmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)August 7, 2025 | globenewswire.comShort Interest in Genmab A/S Sponsored ADR (NASDAQ:GMAB) Grows By 109.1%August 6, 2025 | marketbeat.comXTX Topco Ltd Acquires Shares of 30,929 Genmab A/S Sponsored ADR (NASDAQ:GMAB)August 6, 2025 | marketbeat.com72,394 Shares in Genmab A/S Sponsored ADR (NASDAQ:GMAB) Acquired by Avantax Advisory Services Inc.August 2, 2025 | marketbeat.comGenmab A/S (GMAB) Projected to Post Quarterly Earnings on ThursdayAugust 1, 2025 | marketbeat.comBank of New York Mellon Corp Has $1.05 Million Stake in Genmab A/S Sponsored ADR (NASDAQ:GMAB)August 1, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Upgraded at Wall Street ZenJuly 28, 2025 | marketbeat.comTD Cowen Maintains a Hold on Genmab A/S (GMAB)July 28, 2025 | msn.comY Intercept Hong Kong Ltd Reduces Position in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 27, 2025 | marketbeat.comMadison Asset Management LLC Boosts Stock Position in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 25, 2025 | marketbeat.comTruist Securities Hikes Genmab A/S (GMAB) Price Target Buoyed by Revenue OutlookJuly 25, 2025 | msn.com14,128 Shares in Genmab A/S Sponsored ADR (NASDAQ:GMAB) Acquired by Wealth Alliance LLCJuly 23, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Downgraded to "Hold" Rating by Wall Street ZenJuly 20, 2025 | marketbeat.comGenmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Purchased by Envestnet Asset Management Inc.July 19, 2025 | marketbeat.comDDD Partners LLC Has $11.77 Million Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 16, 2025 | marketbeat.comGenmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025July 16, 2025 | globenewswire.comGenmab A/S FY2025 EPS Estimate Boosted by William BlairJuly 15, 2025 | marketbeat.comTruist Financial Remains a Buy on Genmab (GMAB)July 10, 2025 | theglobeandmail.comChina Universal Asset Management Co. Ltd. Has $905,000 Stock Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 9, 2025 | marketbeat.com14,361 Shares in Genmab A/S Sponsored ADR (NASDAQ:GMAB) Acquired by Callan Capital LLCJuly 9, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Stock Price Expected to Rise, Truist Financial Analyst SaysJuly 8, 2025 | marketbeat.com Get Genmab A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GMAB Media Mentions By Week GMAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GMAB News Sentiment▼1.081.09▲Average Medical News Sentiment GMAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GMAB Articles This Week▼97▲GMAB Articles Average Week Get the Latest News and Ratings for GMAB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Genmab A/S and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Insmed News Today BioNTech News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Viatris News Today Dr. Reddy's Laboratories News Today Ascendis Pharma A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GMAB) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GMAB Stock Alerts